Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection …

Background The accuracy of alpha‐fetoprotein (AFP) as a diagnostic marker for
hepatocellular carcinoma (HCC) is insufficient, and the application of abnormal prothrombin …

Background Prothrombin induced by vitamin K absence or antagonist‐II (PIVKA‐II) and
alpha fetoprotein (AFP) are biomarkers for hepatocellular carcinoma (HCC). However, their …

Simple Summary The prognosis of hepatocellular carcinoma is mainly driven by the stage of
the tumor and by the overall liver function status. However, survival rates of patients with …

Objective: This study aimed to compare the effects of ultrasound and CT-guided
radiofrequency ablation (RFA) on liver function, serum antagonist-II (PIVKA-II), alpha …

Background/purpose Prothrombin Induced by Vitamin K Absence or Antagonist-II (PIVKA-II)
is a diagnostic marker for hepatocellular carcinoma (HCC). Transarterial chemoembolization …

Aim Liver fibrosis influences liver regeneration and surgical outcomes. The fibrosis-4 (FIB-4)
index is strongly associated with liver fibrosis and cirrhosis. This study aimed to examine the …

In patients with AFP‑negative hepatocellular carcinoma (HCC), des‑γ‑carboxyprothrombin
(DCP) is an important prognostic indicator for the preoperative assessment of transarterial …

Hepatocellular cancer (HCC) is one of the main reasons for liver transplantation (LT).
Biomarkers, such as alpha-foetoprotein (AFP) and Des-gamma-carboxy-prothrombin (DCP) …

Abstract Background PIVKA-II (DCP) is increasingly used for the diagnosis and the
surveillance of hepatocellular carcinoma (HCC) in at-risk populations. However, to date, few …